607 related articles for article (PubMed ID: 25401301)
21. Distinct Genomic Copy Number Alterations Distinguish Mucinous Tubular and Spindle Cell Carcinoma of the Kidney From Papillary Renal Cell Carcinoma With Overlapping Histologic Features.
Ren Q; Wang L; Al-Ahmadie HA; Fine SW; Gopalan A; Sirintrapun SJ; Tickoo SK; Reuter VE; Chen YB
Am J Surg Pathol; 2018 Jun; 42(6):767-777. PubMed ID: 29462091
[TBL] [Abstract][Full Text] [Related]
22. MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features.
Denize T; Just PA; Sibony M; Blons H; Timsit MO; Drossart T; Jakubowicz D; Broudin C; Morini A; Molina T; Vano Y; Auvray-Kuentz M; Richard S; Mejean A; Gimenez Roqueplo AP; Burnichon N; Verkarre V
Mod Pathol; 2021 Mar; 34(3):647-659. PubMed ID: 32770124
[TBL] [Abstract][Full Text] [Related]
23. Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases.
Marsaud A; Dadone B; Ambrosetti D; Baudoin C; Chamorey E; Rouleau E; Lefol C; Roussel JF; Fabas T; Cristofari G; Carpentier X; Michiels JF; Amiel J; Pedeutour F
Genes Chromosomes Cancer; 2015 Jun; 54(6):369-82. PubMed ID: 25820192
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.
Pan CC; Chen PC; Chiang H
Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361
[TBL] [Abstract][Full Text] [Related]
25. Novel mutations of the MET proto-oncogene in papillary renal carcinomas.
Schmidt L; Junker K; Nakaigawa N; Kinjerski T; Weirich G; Miller M; Lubensky I; Neumann HP; Brauch H; Decker J; Vocke C; Brown JA; Jenkins R; Richard S; Bergerheim U; Gerrard B; Dean M; Linehan WM; Zbar B
Oncogene; 1999 Apr; 18(14):2343-50. PubMed ID: 10327054
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA profiling of human kidney cancer subtypes.
Petillo D; Kort EJ; Anema J; Furge KA; Yang XJ; Teh BT
Int J Oncol; 2009 Jul; 35(1):109-14. PubMed ID: 19513557
[TBL] [Abstract][Full Text] [Related]
27. Deregulation of PAX2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis.
Patrício P; Ramalho-Carvalho J; Costa-Pinheiro P; Almeida M; Barros-Silva JD; Vieira J; Dias PC; Lobo F; Oliveira J; Teixeira MR; Henrique R; Jeronimo C
J Cell Mol Med; 2013 Aug; 17(8):1048-58. PubMed ID: 23890189
[TBL] [Abstract][Full Text] [Related]
28. Next-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling genes.
Malouf GG; Su X; Yao H; Gao J; Xiong L; He Q; Compérat E; Couturier J; Molinié V; Escudier B; Camparo P; Doss DJ; Thompson EJ; Khayat D; Wood CG; Yu W; Teh BT; Weinstein J; Tannir NM
Clin Cancer Res; 2014 Aug; 20(15):4129-40. PubMed ID: 24899691
[TBL] [Abstract][Full Text] [Related]
29. [Non clear cell renal cell carcinoma. 2008 update in renal tumor pathology].
Sibony M; Vieillefond A
Ann Pathol; 2008 Oct; 28(5):381-401. PubMed ID: 19068393
[TBL] [Abstract][Full Text] [Related]
30. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
[TBL] [Abstract][Full Text] [Related]
31. A collision tumor of papillary renal cell carcinoma and oncocytoma: case report and literature review.
Goyal R; Parwani AV; Gellert L; Hameed O; Giannico GA
Am J Clin Pathol; 2015 Nov; 144(5):811-6. PubMed ID: 26486747
[TBL] [Abstract][Full Text] [Related]
32. The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to Tumorigenesis.
Joshi S; Tolkunov D; Aviv H; Hakimi AA; Yao M; Hsieh JJ; Ganesan S; Chan CS; White E
Cell Rep; 2015 Dec; 13(9):1895-908. PubMed ID: 26655904
[TBL] [Abstract][Full Text] [Related]
33. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
Velickovic M; Delahunt B; Störkel S; Grebem SK
Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
[TBL] [Abstract][Full Text] [Related]
34. Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma.
Wu P; Liu JL; Pei SM; Wu CP; Yang K; Wang SP; Wu S
BMC Cancer; 2018 Mar; 18(1):287. PubMed ID: 29534679
[TBL] [Abstract][Full Text] [Related]
35. Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population.
Lindor NM; Dechet CB; Greene MH; Jenkins RB; Zincke MT; Weaver AL; Wilson M; Zincke H; Liu W
Genet Test; 2001; 5(2):101-6. PubMed ID: 11551094
[TBL] [Abstract][Full Text] [Related]
36. A genomic algorithm for the molecular classification of common renal cortical neoplasms: development and validation.
Gowrishankar B; Przybycin CG; Ma C; Nandula SV; Rini B; Campbell S; Klein E; Chaganti RS; Magi-Galluzzi C; Houldsworth J
J Urol; 2015 May; 193(5):1479-85. PubMed ID: 25498568
[TBL] [Abstract][Full Text] [Related]
37. Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms.
Skala SL; Wang X; Zhang Y; Mannan R; Wang L; Narayanan SP; Vats P; Su F; Chen J; Cao X; Siddiqui J; Argani P; Cieślik MP; Giordano TJ; Chinnaiyan AM; Dhanasekaran SM; Mehra R
Eur Urol; 2020 Jul; 78(1):63-74. PubMed ID: 32299640
[TBL] [Abstract][Full Text] [Related]
38. CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma.
Sukov WR; Ketterling RP; Lager DJ; Carlson AW; Sinnwell JP; Chow GK; Jenkins RB; Cheville JC
Hum Pathol; 2009 Sep; 40(9):1296-303. PubMed ID: 19386349
[TBL] [Abstract][Full Text] [Related]
39. Lack of mutation of the folliculin gene in sporadic chromophobe renal cell carcinoma and renal oncocytoma.
Nagy A; Zoubakov D; Stupar Z; Kovacs G
Int J Cancer; 2004 Apr; 109(3):472-5. PubMed ID: 14961590
[TBL] [Abstract][Full Text] [Related]
40. Papillary renal cell carcinoma with a somatic mutation in MET in a patient with autosomal dominant polycystic kidney disease.
Zhang W; Tan AY; Blumenfeld J; Liu G; Michaeel A; Zhang T; Robinson BD; Salvatore SP; Kapur S; Donahue S; Bobb WO; Rennert H
Cancer Genet; 2016; 209(1-2):11-20. PubMed ID: 26718059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
